3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Head and Neck Neoplasms
1
Interventions
vandetanib
1
pembrolizumab
1
lenvatinib
1
fosbretabulin
1
fludarabine
1
combretastatin
1
aldesleukin
1
Water
1
Thyroxine
1
Thyrotropin-Releasing Hormone
1
Tea
1
Paclitaxel
1
Milk
1
Iodine-124
1
Iodine-123
1
Fluorodeoxyglucose F18
1
Drug Therapy
1
Docetaxel
1
DNA
1
Cyclophosphamide
1
Coffee
1
Carboplatin
1
Biopsy, Fine-Needle
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Thyroid Neoplasms
×
fosbretabulin
×
Clear all
NCT01701349
2014-05-01
FACT2
Mateon Therapeutics
Phase 3
Withdrawn